Close Menu

NEW YORK – A molecular diagnostic test kit from SpeeDx to detect the sexually transmitted infection Mycoplasma genitalium as well as genetic mutations conferring resistance to macrolides, a commonly-prescribed class of antibiotics, has been cleared by Health Canada.

The qPCR kit, called ResistancePlus MG, is the first test commercially available in Canada that can be used for both pathogen identification and therapy guidance, according to the Sydney, Australia-based firm.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
16
Sponsored by
ArcherDX

This webinar will discuss a next-generation sequencing approach for detecting genomic mutations in hematologic maglignancies.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.